An mHealth hybrid app for self-reporting pain measures for sickle cell disease

Kevin Gary, Pooja Rallabhandi, Elizabeth Walek, Margaret Nettleton, Ishrat Ahmed, Jishuan Wang, Kevin Cleary, Zena Quezado

Research output: Chapter in Book/Report/Conference proceedingConference contribution

5 Scopus citations

Abstract

The utilization of acute health care and readmission rates among sickle cell disease patients are very high and are associated with significant health care costs and disparities. Mobile technology can help assess adherence to therapeutic interventions in sickle cell disease and other pain syndromes, and decrease barriers to continuity of care (i.e., limited hospital access, travel difficulties). However, it is unclear whether this technology can improve monitoring of patients' clinical outcomes (pain, anxiety, fatigue, mobility). In this paper we report on an ongoing project to utilize web and mobile technology to monitor clinical outcomes for patients with sickle cell disease. We share preliminary results of pilot studies using the technology for pediatric patients, and describe our current efforts to reduce hospital readmission rates.

Original languageEnglish (US)
Title of host publication2016 IEEE Healthcare Innovation Point-of-Care Technologies Conference, HI-POCT 2016
PublisherInstitute of Electrical and Electronics Engineers Inc.
Pages179-182
Number of pages4
ISBN (Electronic)9781509011667
DOIs
StatePublished - Dec 27 2016
Event2016 IEEE Healthcare Innovation Point-of-Care Technologies Conference, HI-POCT 2016 - Cancun, Mexico
Duration: Nov 9 2016Nov 11 2016

Publication series

Name2016 IEEE Healthcare Innovation Point-of-Care Technologies Conference, HI-POCT 2016

Other

Other2016 IEEE Healthcare Innovation Point-of-Care Technologies Conference, HI-POCT 2016
Country/TerritoryMexico
CityCancun
Period11/9/1611/11/16

ASJC Scopus subject areas

  • Health Informatics
  • Medicine (miscellaneous)

Fingerprint

Dive into the research topics of 'An mHealth hybrid app for self-reporting pain measures for sickle cell disease'. Together they form a unique fingerprint.

Cite this